vs-6766
Small moleculeexperimental
Clinical trial activity
10 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
9
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2020 (NCT04620330)
Timeline
Indications
Studied for
- Breast Neoplasms · Phase 1/Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Colorectal Neoplasms · Phase 1/Phase 2
- Endometrial Neoplasms · Phase 2
- Melanoma · Phase 2
- Mutation · Phase 2
- Neoplasms · Phase 2
- Ovarian Neoplasms · Phase 2
- Pancreatic Neoplasms · Phase 1/Phase 2
- Pharmacology · Phase 1
- Uterine Cervical Neoplasms · Phase 2
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06682572 | Phase 2 | Oct 30, 2024 | Japanese Gynecologic Oncology Group, Verastem, Inc. |
| NCT05608252 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2023 | Eli Lilly, Harvard University, Verastem, Inc. |
| NCT05669482 | Phase 1/Phase 2 (Phase 2) | Jan 15, 2023 | Verastem, Inc. |
| NCT05512208 | Phase 2 | Dec 31, 2022 | University of Oklahoma, Verastem, Inc. |
| NCT05200442 | Phase 1/Phase 2 (Phase 2) | Aug 22, 2022 | University of Chicago, Verastem, Inc. |
| NCT05074810 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2021 | Amgen, Verastem, Inc. |
| NCT05187169 | Phase 1 | Dec 16, 2021 | Verastem, Inc. |
| NCT04720417 | Phase 2 | Jan 26, 2021 | Thomas Jefferson University, Verastem, Inc. |
| NCT04625270 | Phase 2 | Dec 21, 2020 | European Network for Gynaecological Oncological Trial, GOG Foundation, Inc., Gynecologic Oncology Group, Verastem, Inc. |
| NCT04620330 | Phase 2 | Nov 30, 2020 | University of Colorado, Denver, Verastem, Inc. |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Verastem, Inc. | For profit | 10 | 6 | 2 | 2020 |
| Amgen | For profit | 1 | 0 | 1 | 2021 |
| Eli Lilly | For profit | 1 | 0 | 1 | 2023 |
| European Network for Gynaecological Oncological Trial | Academic/Hospital | 1 | 0 | 1 | 2020 |
| GOG Foundation, Inc. | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Gynecologic Oncology Group | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Japanese Gynecologic Oncology Group | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Thomas Jefferson University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Chicago | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Oklahoma | Academic/Hospital | 1 | 1 | 1 | 2022 |
12 organizations
Page 1 / 1